Scinai Immunotherapeutics (SCNI) Assets Average (2020 - 2026)

Scinai Immunotherapeutics (SCNI) posted Assets Average of $14.6 million for Q1 2026, up 24.5% sequentially from $11.7 million in Q4 2025.

Scinai Immunotherapeutics (SCNI) Assets Average (2020 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Assets Average for 7 years, with the latest figure at $14.6 million in Q1 2026.

Quarterly Assets Average changed N/A year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (changed N/A YoY) and the FY2025 annual result came in at $12.5 million, down 18.91% from the prior year.
Assets Average grew to $14.6 million in Q1 2026 per SCNI's latest filing, from $11.7 million in the prior quarter.
Over five years, Assets Average peaked at $25.2 million in Q1 2023 and troughed at $11.7 million in Q4 2025.
A 5-year average of $18.1 million and a median of $17.6 million in 2023 frame the typical range for Assets Average.
The sharpest annual moves came in 2024 and 2025: Assets Average sank 31.45% in 2024, then declined 8.72% in 2025.
Over 5 years, Assets Average stood at $24.1 million in 2022, then decreased by 25.13% to $18.0 million in 2023, then declined by 28.69% to $12.9 million in 2024, then slipped by 8.72% to $11.7 million in 2025, then grew by 24.5% to $14.6 million in 2026.
According to Business Quant data, Assets Average over the past three periods registered $14.6 million, $11.7 million, and $12.9 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Vertex Pharmaceuticals	139.41 Bn	131.56 Bn	2.84 Bn	26.95 Bn
2	Regeneron Pharmaceuticals	86.14 Bn	78.15 Bn	3.93 Bn	41.30 Bn
3	Argenx Se	65.52 Bn	60.34 Bn	1.37 Bn	-
4	Moderna	58.21 Bn	53.07 Bn	52.00 Mn	11.22 Bn
5	BeOne Medicines	42.15 Bn	37.05 Bn	1.53 Bn	8.86 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn	5.34 Bn
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn	25.27 Bn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	2.09 Bn
9	Royalty Pharma	27.30 Bn	26.46 Bn	-	19.82 Bn
10	Scinai Immunotherapeutics	11.17 Mn	-3.10 Bn	-1.12 Mn	14.61 Mn

Download Data